Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
Heart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients with heart failure with reduced ejection fraction (HFrEF) are...
Guardado en:
Autores principales: | Neal M Dixit, Shivani Shah, Boback Ziaeian, Gregg C Fonarow, Jeffrey J Hsu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca54115097ca404abb834a9b50fca39c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
por: Nicholas K Brownell, et al.
Publicado: (2021) -
Determinants of gait speed in patients with heart failure with reduced ejection fraction
por: Aylin Tanrıverdi, et al.
Publicado: (2021) -
Role of nutritional supplementation in heart failure with reduced ejection fraction
por: Yash Paul Sharma, et al.
Publicado: (2021) -
Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
por: M Rizzo, et al.
Publicado: (2020) -
Classification of heart failure: A farewell to ejection fraction?
por: Thomas F. Lüscher
Publicado: (2021)